Renal Anemia
📧 Sign up to get email alerts when something new happens for Renal Anemia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Update: A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease [Phase 3]
Phase 3 clinical trial evaluating roxadustat to treat anemia in children and adolescents with chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2026-03-04Clinical Trial Update: A Study of Roxadustat to Treat Anemia in Children and Teenagers With Chronic Kidney Disease [Phase 3]
Phase 3 clinical trial evaluating Roxadustat for anemia in children and adolescents with chronic kidney disease is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-07-25Clinical Trial Update: Post-marketing Surveillance of EVRENZO® Tablets (Roxadustat) in Patients With Renal Anemia
Post-marketing surveillance results for Roxadustat (EVRENZO) in patients with renal anemia; the study has completed and results have been re…
-
CLINICAL_TRIALS trial_result · 2025-07-23Clinical Trial Update: Enarodustat Tablets at Different Initial Doses for Anemia in Non-dialysis CKD Patients [Phase 4]
A Phase 4 trial is evaluating different initial doses of enarodustat tablets for anemia in non-dialysis chronic kidney disease patients; the…
-
CLINICAL_TRIALS trial_result · 2025-05-15Clinical Trial Update: HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia [Phase 1]
This update confirms the completion of a Phase Ib study of HEC53856 in non-dialysis patients with renal anemia associated with chronic kidne…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: A Prospective Interventional Study Assessing the Clinical and Operational Effectiveness of Transitioning From Mircera to Daprodustat for the Treatment of Anemia in End Stage Kidney Disease [Phase 4]
A Phase 4 interventional study evaluating the clinical and operational effectiveness of transitioning from Mircera to Daprodustat for the tr…
-
CLINICAL_TRIALS trial_result · 2023-12-06Clinical Trial Update: Study to Compare the Safety and Efficacy of UB-851 and Eprex® [Phase 3]
Phase 3 study comparing UB-851 to Eprex in renal anemia has completed.
-
CLINICAL_TRIALS trial_result · 2023-11-22Clinical Trial Update: Pharmacokinetics Comparison Study of JT1801 and NESP® After Single Dose Administration in Chinese Health Male Volunteers [Phase 4]
Phase 4 pharmacokinetics study comparing JT1801 with NESP after a single dose in healthy Chinese male volunteers completed.
-
CLINICAL_TRIALS trial_result · 2023-10-04Clinical Trial Update: A Study of AND017 to Treat Anemia in Non-dialysis-Dependent Chronic Kidney Disease (NDD-CKD) Patients [Phase 2]
Phase 2 trial update for AND017 in treating anemia in non-dialysis-dependent chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2022-11-29Clinical Trial Update: A Study of PEG-EPO Injection (CHO Cells) for Maintenance Therapy of Patients With Renal Anemia . [Phase 2]
Phase 2 clinical trial update on PEG-EPO Injection (CHO Cells) for maintenance therapy in renal anemia.
-
CLINICAL_TRIALS trial_result · 2022-11-23Clinical Trial Update: Biosimilar Erythropoietin in Anaemia Treatment (Maintenance Phase Study) [Phase 3]
Phase 3 trial update for a biosimilar erythropoietin in renal anemia has completed.
-
CLINICAL_TRIALS trial_result · 2022-08-16Clinical Trial Update: Acute Effects of Intravenous Iron on Oxidative Stress and Endothelial Dysfunction in Non-dialysis CKD [Phase 4]
Phase 4 clinical trial assessing the acute effects of intravenous iron on oxidative stress and endothelial dysfunction in non-dialysis chron…
-
CLINICAL_TRIALS trial_result · 2021-11-26Clinical Trial Update: Different Doses of Roxadustat Treatment for Anemia in Peritoneal Dialysis Patients [Phase 4]
Phase 4 clinical trial evaluating different doses of roxadustat for anemia in patients undergoing peritoneal dialysis completed.
-
CLINICAL_TRIALS trial_result · 2021-01-29Clinical Trial Update: A Study of Molidustat for Treatment of Renal Anemia in Peritoneal Dialysis Subjects [Phase 3]
Phase 3 trial update of molidustat for renal anemia in peritoneal dialysis patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-11-13Clinical Trial Update: Phase III Study of GSK1278863 in Japanese Non-dialysis (ND) and Peritoneal Dialysis (PD) Subjects With Renal Anemia [Phase 3]
Phase III study of GSK1278863 in Japanese non-dialysis and peritoneal dialysis patients with renal anemia has completed; results posted in 2…
-
CLINICAL_TRIALS trial_result · 2019-04-02Clinical Trial Update: A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD) [Phase 3]
Phase III study of JR-131 in renal anemia patients with chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2018-08-15Clinical Trial Update: A Study to Assess All-Cause Mortality and Cardiovascular Morbidity in Participants With Chronic Kidney Disease (CKD) on Dialysis and Those Not on Renal Replacement Therapy Receiving Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) or Reference Erythropoietin Stimulating Agents (ESAs) [Phase 4]
Phase 4 trial updating all-cause mortality and cardiovascular outcomes in CKD patients on dialysis or not, comparing Mircera to reference ES…
-
CLINICAL_TRIALS trial_result · 2017-09-08Clinical Trial Update: Study to Determine Optimum Intravenous Starting Dose of MIRCERA for Treatment of Pediatric Participants With Anemia and Chronic Kidney Disease on Hemodialysis [Phase 2]
Phase 2 trial update evaluating the optimum intravenous starting dose of MIRCERA for treatment of pediatric anemia due to chronic kidney dis…
-
CLINICAL_TRIALS trial_result · 2007-12-20Clinical Trial Update: A Study of NeoRecormon (Epoetin Beta) in Patients With Renal Anemia. [Phase 4]
A Phase 4 study evaluating NeoRecormon (epoetin beta) in patients with renal anemia was terminated.
-
CLINICAL_TRIALS trial_result · 2007-11-06Clinical Trial Update: A Randomized Study of the Safety and Efficacy of FG-2216 in Subjects With Renal Anemia Not Requiring Dialysis and Not Receiving Recombinant Human Erythropoietin [Phase 2]
Phase 2 randomized trial evaluating the safety and efficacy of FG-2216 in renal anemia patients not requiring dialysis and not receiving rec…
-
CLINICAL_TRIALS trial_result · 2006-07-21Clinical Trial Update: Comparison of Epoetin Alfa and Epoetin Omega in Anemic Dialysis Patients:Results of Efficacy Trial [Phase 3]
A Phase 3 trial comparing efficacy of epoetin alfa versus epoetin omega in anemic dialysis patients with end-stage renal disease. The study …